EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Role of asenapine as an augmenter for treatment-resistant schizophrenia

Wisam Al Jumaili, Shailesh Jain

Psychiatry Research Case Reports · 2022

DOI: 10.1016/j.psycr.2022.100019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychiatry Research Case Reports, 2022. Verfasst von Wisam Al Jumaili und 1 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Case reportMs.C is a 35-year-old single Caucasian female with TRS admitted involuntarily to an inpatient psychiatric hospital for stabilization after showing disorganized behavior and speech.For the last 12 years, Ms. C carries a diagnosis of schizophrenia, the patient has been treated at high-security hospitals with multiple admissions and high dose, high

Zitieren

APA

Jumaili, W. A., & Jain, S. (2022). Role of asenapine as an augmenter for treatment-resistant schizophrenia. Psychiatry Research Case Reports. https://doi.org/10.1016/j.psycr.2022.100019

Vancouver

Jumaili WA, Jain S. Role of asenapine as an augmenter for treatment-resistant schizophrenia. Psychiatry Research Case Reports. 2022. doi:10.1016/j.psycr.2022.100019

BibTeX
@article{Jumaili2022,
  author = {Jumaili, Wisam Al and Jain, Shailesh},
  title = {Role of asenapine as an augmenter for treatment-resistant schizophrenia},
  journal = {Psychiatry Research Case Reports},
  year = {2022},
  doi = {10.1016/j.psycr.2022.100019}
}
Kostenlos starten →